Latest Market Research Report 2025

  Clinical Trial Supplies   Industry Overview The global clinical trial supplies market size was estimated at USD 2.58 billion in 2023   and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. Globalization, and rise in the number of biologics & biosimilar drugs in clinical trials are among the major factors expected to drive the market growth. Rapid adoption of a supply chain management system to surmount R&D expenditure pressure and increase operational efficiency, as clinical trial supplies account for a large share of the total R&D expenditure of biopharmaceutical companies, is anticipated to propel market growth in near future. There has been a significant rise in   biologics and temperature-sensitive drugs in clinical trials. Most clinical trials are currently being conducted in developing economies. The increasing cost of clinical trials and complications in the recruitment of pati...

  Clinical Trial Supplies   Industry Overview   The global clinical trial supplies market size was estimated at USD 3.97 billion in 2030 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.   Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during...

  Clinical Trial Supplies Industry Overview The global clinical trial supplies market size was valued at USD 2.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030. The growth is attributed to globalization, a rise in the number of clinical trials, and an increase in the number of biologics & biosimilar drugs in clinical trials. The COVID-19 pandemic has negatively impacted the market, resulting in a low growth rate in 2020 and the first half of 2021. This, in turn, has further propelled technological advancements in supply chain management, which is expected to contribute to market growth in the long run. The adoption of supply chain management systems is increasing due to rising pressure to reduce R&D expenditure and increase operational efficiency, as clinical trial supplies account for a large share of the total R&D expenditure of biopharmaceutical companies. Gather more insights about the ma...